BACE1 and neuroblastoma: Additionally, no effects on the BACE1 protein and BACE1 mRNA expression by treatment with hrANXA1 (0.5–2 μg/ml) were confirmed in N2asw and in human neuroblastoma SK-N-SH cells (Fig. 3b–d).